Cargando…

Effectiveness of Megestrol for the Treatment of Patients with Atypical Endometrial Hyperplasia or Endometrial Endometrioid Adenocarcinoma (Stage IA, Well Differentiated)

OBJECTIVE: We aimed to evaluate treatment responses and recurrence rate of atypical endometrial hyperplasia (AEH) and endometrial endometrioid adenocarcinoma (EA) with Stage IA Grade 1 to megestrol in Iranian patients who are candidates for medical treatments. METHODS: In a retrospective cohort stud...

Descripción completa

Detalles Bibliográficos
Autores principales:	Akhavan, Setareh, Sabet, Fahimeh, Mousavi, Azam-Sadat, Gilani, Mitra Modarres, Hasani, Shahrzad Sheikh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8809456/ https://www.ncbi.nlm.nih.gov/pubmed/35198507 http://dx.doi.org/10.4103/jrpp.JRPP_20_128

Ejemplares similares

Conservative therapy with metformin plus megestrol acetate for endometrial atypical hyperplasia
por: Shan, Weiwei, et al.
Publicado: (2014)

Hysteroscopic Curettage Followed by Megestrol Acetate Plus Metformin as a Fertility-Sparing Treatment for Women with Atypical Endometrial Hyperplasia or Well-Differentiated Endometrioid Endometrial Carcinoma
por: Jing, Chu-Yu, et al.
Publicado: (2022)

Vulvar cancer in Iran: Retrospective study over 20 years (1998-2018)
por: Mousavi, Azamosadat, et al.
Publicado: (2019)

The Outcome of Locally Advanced Cervical Cancer in Patients Treated with Neoadjuvant Chemotherapy Followed by Radical Hysterectomy and Primary Surgery
por: Mousavi, Azamsadat, et al.
Publicado: (2021)

The present status of metformin in fertility-preserving treatment in atypical endometrial hyperplasia and endometrioid endometrial cancer
por: Guan, Jun, et al.
Publicado: (2022)

The prognosis of stage IA synchronous endometrial endometrioid and ovarian carcinomas
por: Zhan, Xiangbo, et al.
Publicado: (2019)

Does Postevacuation β-Human Chorionic Gonadotropin Level Predict the Persistent Gestational Trophoblastic Neoplasia?
por: Mousavi, Azam Sadat, et al.
Publicado: (2014)

Rapid identification of endometrial hyperplasia and endometrial endometrioid cancer in young women
por: Kuai, Dan, et al.
Publicado: (2023)

Placenta Site Trophoblastic Tumor and Choriocarcinoma from Previous Cesarean Section Scar: Case Reports
por: Nasiri, Setare, et al.
Publicado: (2018)

Prognostic factors for tumor recurrence in endometrioid endometrial cancer stages IA and IB
por: Han, Kyung Hee, et al.
Publicado: (2017)

The Prognostic Value of Retroperitoneal Lymphadenectomy in Apparent Stage IA Endometrial Endometrioid Cancer
por: Liu, Zhao, et al.
Publicado: (2021)

Use of clinicopathological factors to predict prognosis of fertility-sparing treatment for endometrial endometrioid carcinoma and atypical hyperplasia
por: Zhang, Xiaobo, et al.
Publicado: (2022)

Identification of potential models for predicting progestin insensitivity in patients with endometrial atypical hyperplasia and endometrioid endometrial cancer based on ATAC-Seq and RNA-Seq integrated analysis
por: Hu, Jia-Li, et al.
Publicado: (2022)

PTEN mutation predicts unfavorable fertility preserving treatment outcome in the young patients with endometrioid endometrial cancer and atypical hyperplasia
por: Xue, Yu, et al.
Publicado: (2023)

Norethindrone substituted for megestrol in the treatment of metastatic endometrial carcinoma: Three cases
por: Read, William L., et al.
Publicado: (2017)

Expression of the VEGF and angiopoietin genes in endometrial atypical hyperplasia and endometrial cancer
por: Holland, C M, et al.
Publicado: (2003)

Fertility-Sparing Treatment in Young Patients With Grade 2 Presumed Stage IA Endometrioid Endometrial Adenocarcinoma
por: Yu, Mei, et al.
Publicado: (2020)

Levonorgestrel-releasing intrauterine device plus metformin, or megestrol acetate plus metformin for fertility-sparing treatment of atypical endometrial hyperplasia and early endometrial carcinoma: a prospective, randomized, blind-endpoint design trial protocol
por: Zhao, Xin, et al.
Publicado: (2022)

Lymph node dissection in atypical endometrial hyperplasia
por: Taşkın, Salih, et al.
Publicado: (2017)

Fertility-Sparing Treatment for Endometrial Cancer or Atypical Endometrial Hyperplasia Patients With Obesity
por: Chen, Junyu, et al.
Publicado: (2022)

Laparoscopic Surgery for Atypical Endometrial Hyperplasia with Awareness Regarding the Possibility of Endometrial Cancer
por: Kamii, Misato, et al.
Publicado: (2022)

PPOS Protocol Effectively Improves the IVF Outcome Without Increasing the Recurrence Rate in Early Endometrioid Endometrial Cancer and Atypical Endometrial Hyperplasia Patients After Fertility Preserving Treatment
por: Chen, Jiazhou, et al.
Publicado: (2021)

Hypoxia and Angiogenesis in Endometrioid Endometrial Carcinogenesis
por: Horrée, Nicole, et al.
Publicado: (2007)

VEGF Immunoexpression in Endometrioid Endometrial Carcinomas
por: DROCAŞ, ILEANA, et al.
Publicado: (2022)

Snail Immunoexpression in Endometrioid Endometrial Carcinomas
por: FLORESCU, MIRELA MARINELA, et al.
Publicado: (2022)

Diagnostic Accuracy of Hysteroscopic Scoring System in Predicting Endometrial Malignancy and Atypical Endometrial Hyperplasia
por: Harika, Bhukya, et al.
Publicado: (2021)

Conservative Management of Atypical Endometrial Hyperplasia and Early Endometrial Cancer in Childbearing Age Women
por: Uccella, Stefano, et al.
Publicado: (2022)

Value of endometrial thickness for the detection of endometrial cancer and atypical hyperplasia in asymptomatic postmenopausal women
por: Zhang, Linna, et al.
Publicado: (2022)

Look at This Swelling: Retroauricular Mass as Atypical Progression in Long-Survivor Endometrial Endometrioid Adenocarcinoma
por: De Felice, Marco, et al.
Publicado: (2023)

Audit of waiting time‐to‐treatment of atypical endometrial hyperplasia
por: Anderson, Annabel, et al.
Publicado: (2022)

Risk of atypical hyperplasia and endometrial carcinoma after initial diagnosis of non-atypical endometrial hyperplasia: A long-term follow-up study
por: Prip, Clara M., et al.
Publicado: (2022)

Clinicopathological Prognostic Parameters of Endometrioid Endometrial Carcinomas
por: DROCAŞ, ILEANA, et al.
Publicado: (2022)

Personalized treatment strategy for atypical endometrial hyperplasia with regards to age, comorbidities and endometrial receptor status
por: Goncharenko, Vadym M, et al.
Publicado: (2014)

Pregnancy outcomes of women who received conservative therapy for endometrial carcinoma or atypical endometrial hyperplasia
por: Matsuzaki, Toshiya, et al.
Publicado: (2018)

miRNAs as Candidate Biomarker for the Accurate Detection of Atypical Endometrial Hyperplasia/Endometrial Intraepithelial Neoplasia
por: Giglio, Simona, et al.
Publicado: (2019)

Massively parallel sequencing of endometrial lavage specimens for the detection of cancer-associated mutations in atypical and non-atypical endometrial hyperplasia
por: Weng, Cindy Hsuan, et al.
Publicado: (2022)

Pterostilbene, a natural phenolic compound, synergizes the antineoplastic effects of megestrol acetate in endometrial cancer
por: Wen, Wei, et al.
Publicado: (2017)

The impact of lymphovascular space invasion on survival in early stage low-grade endometrioid endometrial cancer
por: Yarandi, Fariba, et al.
Publicado: (2023)

The PTEN, BAX, and IGFIIR Genes Are Mutated in Endometrial Atypical Hyperplasia
por: Yoshinaga, Kousuke, et al.
Publicado: (1998)

Simultaneous FTIR and Raman Spectroscopy in Endometrial Atypical Hyperplasia and Cancer
por: Barnas, Edyta, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_l51k8d73sdlu3fb7s1prfmf7ev